CVR number 38818457
Industry 86.2300 Dental practice activities

Tandlæge Julie Christiansen ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.7% 4.0% 1.7% 1.6% 1.0%  
Credit score (0-100)  74 49 72 74 86  
Credit rating  A BBB A A A  
Credit limit (kDKK)  2.1 0.0 3.4 5.6 336.2  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Gross profit  8,467 8,191 9,616 9,599 12,835  
EBITDA  1,589 771 1,548 1,278 2,809  
EBIT  714 -173 858 585 2,050  
Pre-tax profit (PTP)  327.7 -533.7 548.3 306.2 1,683.2  
Net earnings  254.7 -417.6 424.5 238.7 1,310.2  
Pre-tax profit without non-rec. items  328 -534 548 306 1,683  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Tangible assets total  3,266 2,925 2,526 2,336 2,890  
Shareholders equity total  697 279 704 829 2,025  
Interest-bearing liabilities  7,271 5,984 5,299 5,230 3,638  
Balance sheet total (assets)  9,401 8,836 8,074 7,550 7,892  
Net Debt  7,239 5,876 5,206 5,180 3,605  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  8,467 8,191 9,616 9,599 12,835  
Gross profit growth  6.3% -3.3% 17.4% -0.2% 33.7%  
Employees  14 15 15 15 17  
Employee growth %  0.0% 7.1% 0.0% 0.0% 13.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  9,401 8,836 8,074 7,550 7,892  
Balance sheet change%  4.3% -6.0% -8.6% -6.5% 4.5%  
Added value  714.3 -173.0 857.6 585.1 2,050.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -343 -1,577 -1,381 -1,174 -495  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  8.4% -2.1% 8.9% 6.1% 16.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  7.8% -1.9% 10.2% 7.6% 26.7%  
ROI %  8.9% -2.3% 13.3% 9.5% 32.6%  
ROE %  44.7% -85.6% 86.4% 31.1% 91.8%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  7.4% 3.2% 8.8% 11.1% 25.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  455.6% 761.9% 336.3% 405.4% 128.4%  
Gearing %  1,043.6% 2,144.0% 753.1% 630.6% 179.6%  
Net interest  0 0 0 0 0  
Financing costs %  5.3% 5.5% 5.6% 5.4% 8.5%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.1 0.2 0.1 0.1 0.2  
Current Ratio  0.2 0.2 0.2 0.2 0.2  
Cash and cash equivalent  31.9 108.3 93.3 50.0 32.2  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -3,328.3 -2,593.0 -3,592.7 -2,819.4 -2,660.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  51 -12 57 39 121  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  113 51 103 85 165  
EBIT / employee  51 -12 57 39 121  
Net earnings / employee  18 -28 28 16 77